Noctor Eoin, Dunne Fidelma P
Eoin Noctor, Steno Diabetes Center, DK-2820 Gentofte, Denmark.
World J Diabetes. 2015 Mar 15;6(2):234-44. doi: 10.4239/wjd.v6.i2.234.
A previous diagnosis of gestational diabetes (GDM) carries a lifetime risk of progression to type 2 diabetes of up to 60%. Identification of those women at higher risk of progression to diabetes allows the timely introduction of measures to delay or prevent diabetes onset. However, there is a large degree of variability in the literature with regard to the proportion of women with a history of GDM who go on to develop diabetes. Heterogeneity between cohorts with regard to diagnostic criteria used, duration of follow-up, and the characteristics of the study population limit the ability to make meaningful comparisons across studies. As the new International Association for Diabetes in Pregnancy Study Group criteria are increasingly adopted worldwide, the prevalence of GDM is set to increase by two-to three-fold. Here, we review the literature to examine the evolution of diagnostic criteria for GDM, the implications of changing criteria on the proportion of women with previous GDM progressing to diabetes, and how the use of different diagnostic criteria may influence the development of appropriate follow-up strategies.
既往诊断为妊娠期糖尿病(GDM)的女性终生进展为2型糖尿病的风险高达60%。识别那些进展为糖尿病风险较高的女性,有助于及时采取措施延缓或预防糖尿病的发生。然而,关于有GDM病史的女性发展为糖尿病的比例,文献中存在很大差异。不同队列在诊断标准、随访时间以及研究人群特征方面的异质性,限制了跨研究进行有意义比较的能力。随着新的国际妊娠糖尿病研究组标准在全球越来越多地被采用,GDM的患病率预计将增加两到三倍。在此,我们回顾文献,以研究GDM诊断标准的演变、标准变化对既往有GDM的女性进展为糖尿病比例的影响,以及不同诊断标准的使用如何影响适当随访策略的制定。